Mon, 29 Sep 2008 11:03:07 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/Gastroenterology/podcast_gastroenterology_CME_CE_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Gastroenterology no PeerView Press The purpose of the program is to provide an analysis of the current state of the science in managing constipation-related disorders such as irritable bowel syndrome with constipation and chronic constipation, and what is needed to further advance understanding and outcomes. Each topic will be analyzed in terms of the potential practical implications of data for diagnosis and management of patients with constipation-related disorders. Please be sure to view the accompanying (PDF) file for full CME/CE information. The purpose of the program is to provide an analysis of the current state of the science in managing constipation-related disorders such as irritable bowel syndrome with constipation and chronic constipation, and what is needed to further advance understanding and outcomes. Each topic will be analyzed in terms of the potential practical implications of data for diagnosis and management of patients with constipation-related disorders. http://podcast.peerviewpress.com/gastroenterology/PA04511FCr388.mp3 http://podcast.peerviewpress.com/Gastroenterology/PA04511FCr388.mp3 Tue, 22 Jul 2008 11:06:19 -0400 Science no 00:20:20 Crohn's disease, IBD, ulcerative colitis, 5-ASA, mucosal healing, immunomodulators, biologics, steroids, step-up, top-down PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA04511FCCMEinfo.pdf http://podcast.peerviewpress.com/Gastroenterology/PA04511FCCMEinfo.pdf Tue, 22 Jul 2008 11:06:00 -0400 Science no 00:00:00 Crohn's disease, IBD, ulcerative colitis, 5-ASA, mucosal healing, immunomodulators, biologics, steroids, step-up, top-down PeerView Press In this activity, an expert in the treatment of inflammatory bowel disease (IBD) uses a case-based format to look at practical issues in the management of patients with IBD. The concepts of "step-up" and "top-down" therapy are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the treatment of inflammatory bowel disease (IBD) uses a case-based format to look at practical issues in the management of patients with IBD. The concepts of "step-up" and "top-down" therapy are featured. http://podcast.peerviewpress.com/gastroenterology/PA04777FCp144.mp3 http://podcast.peerviewpress.com/Gastroenterology/PA04777FCp144.mp3 Thu, 26 Jun 2008 14:45:45 -0400 Science no 00:34:08 Crohn's disease, IBD, ulcerative colitis, 5-ASA, mucosal healing, immunomodulators, biologics, steroids, step-up, top-down PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA04777FCCMEinfo.pdf http://podcast.peerviewpress.com/Gastroenterology/PA04777FCCMEinfo.pdf Thu, 26 Jun 2008 14:45:28 -0400 Science no 00:00:00 Crohn's disease, IBD, ulcerative colitis, 5-ASA, mucosal healing, immunomodulators, biologics, steroids, step-up, top-down PeerView Press The program discusses the common obstacles to achieving good outcomes in patients with chronic constipation. The cost of pharmacologic treatment may be an issue for patients who require long-term management of constipation, and the role of comorbidities must also be considered. The program analyzes the available management strategies for patients with chronic constipation in terms of their risks and benefits. The discussion addresses pharmacologic and nonpharmacologic options and reviews the latest data on safety and efficacy as well as cost-effectiveness for these options. Please be sure to view the accompanying (PDF) file for full CME/CE information. The program discusses the common obstacles to achieving good outcomes in patients with chronic constipation. The cost of pharmacologic treatment may be an issue for patients who require long-term management of constipation, and the role of comorbidities must also be considered. The program analyzes the available management strategies for patients with chronic constipation in terms of their risks and benefits. The discussion addresses pharmacologic and nonpharmacologic options and reviews the latest data on safety and efficacy as well as cost-effectiveness for these options. http://podcast.peerviewpress.com/gastroenterology/PA04931FCn191.mp3 http://podcast.peerviewpress.com/Gastroenterology/PA04931FCn191.mp3 Thu, 19 Jun 2008 16:22:02 -0400 Science clean 00:30:21 constipation, HMO, managed, IBS, cost, lubiprostone, methylnaltrexone, PEG, lactulose, psyllium, lifestyle, bowel PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA04931FCCMEinfo.pdf http://podcast.peerviewpress.com/Gastroenterology/PA04931FCCMEinfo.pdf Thu, 19 Jun 2008 16:21:59 -0400 Science clean 00:00:00 constipation, HMO, managed, IBS, cost, lubiprostone, methylnaltrexone, PEG, lactulose, psyllium, lifestyle, bowel PeerView Press The program focuses on updates and advances in managing constipation-related disorders, based on proceedings of Digestive Disease Week 2008; May 17-22, 2008, San Diego, California. Key discussion topics include etiology of constipation, treatment advances, impact of constipation on quality of life and healthcare resource utilization, and nonpharmacologic treatment options. Please be sure to view the accompanying (PDF) file for full CME/CE information. The program focuses on updates and advances in managing constipation-related disorders, based on proceedings of Digestive Disease Week 2008; May 17-22, 2008, San Diego, California. Key discussion topics include etiology of constipation, treatment advances, impact of constipation on quality of life and healthcare resource utilization, and nonpharmacologic treatment options. http://podcast.peerviewpress.com/gastroenterology/PA04765FCn184.mp3 http://podcast.peerviewpress.com/Gastroenterology/PA04765FCn184.mp3 Mon, 16 Jun 2008 10:25:26 -0400 Science clean 00:21:58 constipation, DDW, digestive, IBS, irritable, bowel, lubiprostone, biofeedback, probiotics, bloating, linaclotide, prucalopride PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA04765FCCMEinfo.pdf http://podcast.peerviewpress.com/Gastroenterology/PA04765FCCMEinfo.pdf Mon, 16 Jun 2008 10:25:21 -0400 Science clean 00:00:00 constipation, DDW, digestive, IBS, irritable, bowel, lubiprostone, biofeedback, probiotics, bloating, linaclotide, prucalopride PeerView Press In this activity, an expert in the treatment of inflammatory bowel disease looks at the role of biologic therapy in the management of patients with IBD. Pivotal trial data on the approved biologics is reviewed and a look at a number of emerging biologics is presented. In addition, strategies for incorporating biologics into the management of patients with IBD are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the treatment of inflammatory bowel disease looks at the role of biologic therapy in the management of patients with IBD. Pivotal trial data on the approved biologics is reviewed and a look at a number of emerging biologics is presented. In addition, strategies for incorporating biologics into the management of patients with IBD are featured. http://podcast.peerviewpress.com/gastroenterology/PA04212FCn182.mp3 http://podcast.peerviewpress.com/Gastroenterology/PA04212FCn182.mp3 Mon, 05 May 2008 16:50:34 -0400 Science clean 00:29:34 IBD, inflammatory, bowel, biologics, Adalimumab, Natalizumab, infliximab, Crohn’s, ulcerative, colitis, Certolizumab, TNF, ACT PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA04212FCCMEinfo.pdf http://podcast.peerviewpress.com/Gastroenterology/PA04212FCCMEinfo.pdf Mon, 05 May 2008 16:50:29 -0400 Science clean 00:00:00 IBD, inflammatory, bowel, biologics, Adalimumab, Natalizumab, infliximab, Crohn’s, ulcerative, colitis, Certolizumab, TNF, ACT PeerView Press In this activity, an expert in the treatment of functional bowel disorders reviews consensus guidelines on the diagnosis of these conditions and evaluates current and emerging therapies for managing them. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the treatment of functional bowel disorders reviews consensus guidelines on the diagnosis of these conditions and evaluates current and emerging therapies for managing them. http://podcast.peerviewpress.com/gastroenterology/PA04222FCn184.mp3 http://podcast.peerviewpress.com/Gastroenterology/PA04222FCn184.mp3 Mon, 31 Mar 2008 10:23:33 -0400 Science clean 00:25:04 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Gastroenterology PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA04222FCCMEinfo.pdf http://podcast.peerviewpress.com/Gastroenterology/PA04222FCCMEinfo.pdf Mon, 31 Mar 2008 10:23:29 -0400 Science clean 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Gastroenterology PeerView Press A review of important issues in chronic constipation and irritable bowel syndrome with constipation. Please be sure to view the accompanying (PDF) file for full CME/CE information. A review of important issues in chronic constipation and irritable bowel syndrome with constipation. http://podcast.peerviewpress.com/gastroenterology/PA03647FCn161.mp3 http://podcast.peerviewpress.com/Gastroenterology/PA03647FCn161.mp3 Tue, 21 Aug 2007 16:01:30 -0400 Science no 00:38:26 Chronic constipation, laxatives, functional bowel disorders, Rome III, IBS-C, probiotics, polyethylene glycol, tegaserod, lubiprostone PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA03647FCCMEinfo.pdf http://podcast.peerviewpress.com/Gastroenterology/PA03647FCCMEinfo.pdf Tue, 21 Aug 2007 16:01:06 -0400 Science no 00:00:00 Chronic constipation, laxatives, functional bowel disorders, Rome III, IBS-C, probiotics, polyethylene glycol, tegaserod, lubiprostone PeerView Press In this activity, experts in the treatment of hepatitis discuss recent data on the efficacy of oral antiviral agents in the management of chronic hepatitis B. An assessment of the long-term risk for developing viral resistance with these agents is featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of hepatitis discuss recent data on the efficacy of oral antiviral agents in the management of chronic hepatitis B. An assessment of the long-term risk for developing viral resistance with these agents is featured. http://podcast.peerviewpress.com/gastroenterology/PA03542FC1s401.mp3 http://podcast.peerviewpress.com/Gastroenterology/PA03542FC1s401.mp3 Fri, 10 Aug 2007 13:42:31 -0400 Science no 00:17:40 Hepatitis B, chronic hepatitis, entecavir, adefovir, lamivudine, telbivudine, DDW, Digestive Disease Week, resistance PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA03542FC1CMEinfo.pdf http://podcast.peerviewpress.com/Gastroenterology/PA03542FC1CMEinfo.pdf Fri, 10 Aug 2007 13:42:16 -0400 Science no 00:00:00 Hepatitis B, chronic hepatitis, entecavir, adefovir, lamivudine, telbivudine, DDW, Digestive Disease Week, resistance PeerView Press In this activity, experts in the management of functional gastrointestinal disorders discuss important issues regarding the management of chronic constipation and irritable bowel syndrome with constipation. Information on the epidemiology, symptomatology, and diagnosis of these conditions is featured, and an assessment of current treatment strategies is highlighted. A look at treatment guidelines and some of the emerging treatment options is also included. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the management of functional gastrointestinal disorders discuss important issues regarding the management of chronic constipation and irritable bowel syndrome with constipation. Information on the epidemiology, symptomatology, and diagnosis of these conditions is featured, and an assessment of current treatment strategies is highlighted. A look at treatment guidelines and some of the emerging treatment options is also included. http://podcast.peerviewpress.com/gastroenterology/PA03867FCn165.mp3 http://podcast.peerviewpress.com/gastroenterology/PA03867FCn165.mp3 Thu, 05 Jul 2007 15:54:21 -0400 Science no 00:35:28 Irritable bowel syndrome, constipation, functional bowel disorders, IBS-C, lubiprostone, tegaserod, PEG, lactulose, antibiotics, renzapride, linaclotide, American College of Physicians Annual Meeting, American Geriatrics Society Annual Meeting, DDW PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this http://podcast.peerviewpress.com/gastroenterology/PA03867FCCMEinfo.mp3 http://podcast.peerviewpress.com/gastroenterology/PA03867FCCMEinfo.pdf Thu, 05 Jul 2007 15:54:04 -0400 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Gastroenterology PeerView Press In this activity, experts discuss the impact of delivery systems on the efficacy and safety of the oral 5-ASA agents used in the management of ulcerative colitis. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts discuss the impact of delivery systems on the efficacy and safety of the oral 5-ASA agents used in the management of ulcerative colitis. http://podcast.peerviewpress.com/gastroenterology/PA03528FCr260.mp3 http://podcast.peerviewpress.com/gastroenterology/PA03528FCr260.mp3 Thu, 12 Apr 2007 14:48:19 -0400 Science no 00:22:18 Ulcerative colitis, inflammatory bowel disease, 5-ASA, mesalamine, sulfasalazine, balsalazide, olsalazine, azo-bond, pH-dependent, SPD476, adherence, delivery system, ASCEND II PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA03528FCCMEinfo.pdf http://podcast.peerviewpress.com/gastroenterology/PA03528FCCMEinfo.pdf Thu, 12 Apr 2007 14:47:52 -0400 Science no 00:00:00 Ulcerative colitis, inflammatory bowel disease, 5-ASA, mesalamine, sulfasalazine, balsalazide, olsalazine, azo-bond, pH-dependent, SPD476, adherence, delivery system, ASCEND II PeerView Press In this activity, experts present an overview on the management of patients with ulcerative colitis with focus on newer treatment options, reduced frequency of dosing, and improving patient outcomes. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts present an overview on the management of patients with ulcerative colitis with focus on newer treatment options, reduced frequency of dosing, and improving patient outcomes. http://podcast.peerviewpress.com/gastroenterology/PA03432FCr252.mp3 http://podcast.peerviewpress.com/gastroenterology/PA03432FCr252.mp3 Thu, 25 Jan 2007 10:23:06 -0500 Science no 00:28:07 Ulcerative colitis,5-ASA,Mesalamine,Aminosalicylates,SPD476,Mesalamine ,microgranules,Mesalamine micropellets,Mesalamine-DR,Mesalamine-SR,Once daily,Adherence,Compliance,CCFA,ASCEND trial,Mucosal healing,Remission,Olasalazine,Sulfasalazine,Balsalazide PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA03432CMEinfo.pdf http://podcast.peerviewpress.com/gastroenterology/PA03432CMEinfo.pdf Thu, 25 Jan 2007 10:22:37 -0500 Science no 00:00:00 Ulcerative colitis,5-ASA,Mesalamine,Aminosalicylates,SPD476,Mesalamine ,microgranules,Mesalamine micropellets,Mesalamine-DR,Mesalamine-SR,Once daily,Adherence,Compliance,CCFA,ASCEND trial,Mucosal healing,Remission,Olasalazine,Sulfasalazine,Balsalazide PeerView Press In this activity, experts present an overview on the management of patients with chronic constipation with focus on newer treatment options and individualized management. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts present an overview on the management of patients with chronic constipation with focus on newer treatment options and individualized management. http://podcast.peerviewpress.com/gastroenterology/PA03616FCs287.mp3 http://podcast.peerviewpress.com/gastroenterology/PA03616FCs287.mp3 Mon, 18 Dec 2006 14:24:42 -0500 Science no 00:22:30 Chronic Constipation, IBS-C, Lubiprostone, Tegaserod , Rome III, Serotonin Receptor, Agonist, Chloride Channel-2 Activator, Elderly, ACG Task Force, Stool Softeners, Stimulant Laxatives, Osmotic Laxatives, Lubricants, Bulking Agents, Psyllium PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA03616FCCMEinfo.pdf http://podcast.peerviewpress.com/gastroenterology/PA03616FCCMEinfo.pdf Mon, 18 Dec 2006 14:24:22 -0500 Science no 00:00:00 Elderly, ACG Task Force, Stool Softeners, Stimulant Laxatives, Osmotic Laxatives, Lubricants, Bulking Agents, Psyllium PeerView Press In this activity, experts present current data on the epidemiology, diagnosis, and management of GER/GERD in children and infants. Diagnostic issues, pharmacologic treatment, and etiology of supraesophageal comorbidities, such as dental carries and asthma, are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts present current data on the epidemiology, diagnosis, and management of GER/GERD in children and infants. Diagnostic issues, pharmacologic treatment, and etiology of supraesophageal comorbidities, such as dental carries and asthma, are featured. http://podcast.peerviewpress.com/gastroenterology/PA02212FCinR173.mp3 http://podcast.peerviewpress.com/gastroenterology/PA02212FCinR173.mp3 Thu, 21 Sep 2006 15:42:15 -0400 Science no 00:33:42 Pediatric GERD, Proton Pump Inhibitors, Lansoprazole, Omeprazole, Esomeprazole, Pantoprazole, Rabeprazole, Asthma, Erosive Esophagitis, Regurgitation, Dental erosion, Pneumonia, Supraesophageal manifestations, Vomiting, GERQ, Tachyphylaxis, Otitis media PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA02212FCCMEinfo.pdf http://podcast.peerviewpress.com/gastroenterology/PA02212FCCMEinfo.pdf Thu, 21 Sep 2006 15:41:49 -0400 Science no 00:00:00 Pediatric GERD, Proton Pump Inhibitors, Lansoprazole, Omeprazole, Esomeprazole, Pantoprazole, Rabeprazole, Asthma, Erosive Esophagitis, Regurgitation, Dental erosion, Pneumonia, Supraesophageal manifestations, Vomiting, GERQ, Tachyphylaxis, Otitis media PeerView Press In this activity, experts in the treatment of gastrointestinal stromal tumors (GIST) present recent data on the efficacy and safety of current and emerging targeted therapies. The effect of genotype on response and dose of medication is also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of gastrointestinal stromal tumors (GIST) present recent data on the efficacy and safety of current and emerging targeted therapies. The effect of genotype on response and dose of medication is also highlighted. http://podcast.peerviewpress.com/gastroenterology/PA03411FCinR214.mp3 http://podcast.peerviewpress.com/gastroenterology/PA03411FCinR214.mp3 Wed, 09 Aug 2006 15:36:56 -0400 Science no 00:18:29 GIST, gastrointestinal stromal tumors, imatinib, sunitinib, nilotinib, surgery, resection, genotype, tyrosine kinase inhibitors, resistance, mutation, metastatic GIST, KIT exon 9, KIT exon 11, PTK787/ZK222584, PDGFR, VEGFR PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA03411FCCMEinfo.pdf http://podcast.peerviewpress.com/gastroenterology/PA03411FCCMEinfo.pdf Wed, 09 Aug 2006 15:36:39 -0400 Science no 00:00:00 GIST, gastrointestinal stromal tumors, imatinib, sunitinib, nilotinib, surgery, resection, genotype, tyrosine kinase inhibitors, resistance, mutation, metastatic GIST, KIT exon 9, KIT exon 11, PTK787/ZK222584, PDGFR, VEGFR PeerView Press In this activity, experts in the management of hepatitis will discuss the expanding treatment options available to treat patients with chronic hepatitis B. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the management of hepatitis will discuss the expanding treatment options available to treat patients with chronic hepatitis B. http://podcast.peerviewpress.com/gastroenterology/PA02121FC1inR147.mp3 http://podcast.peerviewpress.com/gastroenterology/PA02121FC1inR147.mp3 Tue, 27 Jun 2006 16:51:14 -0400 Science no 00:13:06 Pegylated interferon,Entecavir,pegylated interferon alfa-2a,lamivudine,ETV-022 study,chronic hepatitis B,HBV,HbsAg,ALT,seroconversion,side effects,autoimmune thyroiditis,lupus erythematosus,depression,liver failure,cirrhosis,adverse event,safety PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/gastroenterology/PA02121FCCMEinfo.pdf http://podcast.peerviewpress.com/gastroenterology/PA02121FCCMEinfo.pdf Tue, 27 Jun 2006 16:51:09 -0400 Science no 00:00:00 Pegylated interferon,Entecavir,pegylated interferon alfa-2a,lamivudine,ETV-022 study,chronic hepatitis B,HBV,HbsAg,ALT,seroconversion,side effects,autoimmune thyroiditis,lupus erythematosus,depression,liver failure,cirrhosis,adverse event,safety